时隔半年再获融资！上海交大科技成果转化代表企业「肆芃科技」完成数千万元Pre-A+轮融资

Core Viewpoint - SiPeng Technology has successfully completed a multi-million Pre-A+ round of financing, which will be used to accelerate the commercialization of bio-based materials and the construction of a third-generation carbon source bio-manufacturing platform [1][2]. Group 1: Company Overview - SiPeng Technology, established in 2022, focuses on material synthesis and bio-manufacturing, with a founding team that has over 20 years of industry experience [1]. - The company has achieved significant breakthroughs in "bottleneck" technologies and has successfully scaled up multiple bio-manufacturing products [1][2]. - SiPeng Technology is recognized as a representative enterprise for the transformation of scientific achievements from Shanghai Jiao Tong University [1]. Group 2: Financing and Investment - The recent Pre-A+ round was led by Shanghai Guotou Futeng Capital, with XiQiao Capital serving as the exclusive financial advisor [1]. - In October 2024, SiPeng Technology completed a nearly 100 million Pre-A round, which was led by Guotou Chuanghe and followed by Rugao Kechuang Investment [1]. Group 3: Technological Advancements - SiPeng Technology has developed a smart bio-manufacturing platform and a high-performance material application development platform, aiming to produce globally competitive bio-based products [1][2]. - The company has broken the overseas technology monopoly and has completed mass production verification of various bio-based polyols/acids, achieving international leadership in fermentation concentration and cost [1][2]. Group 4: Carbon Source Utilization - SiPeng Technology is collaborating with the Tianjin Institute of Industrial Biotechnology of the Chinese Academy of Sciences to promote the industrialization of bio-based material monomers using methanol as a raw material [2]. - The company is focusing on the industrialization of first and second-generation carbon source products while planning to utilize methanol and carbon dioxide as raw materials for third-generation carbon sources, significantly reducing the reliance on food carbon sources and lowering bio-manufacturing costs [2]. Group 5: Market Outlook - Shanghai Guotou Futeng Capital emphasizes that the synthetic biology field requires both product development and scalable sales for long-term success, aligning with the goals of carbon neutrality and sustainability [4]. - SiPeng Technology aims to establish a long-term market advantage through strain iteration, carbon source replacement, and continuous optimization of production processes [4].